Additionally, using the combined antigens of measles, mumps, and rubella (MMR) may generate a stronger immune response against HPV compared to using a single antigen, positioning MMR as a more effective option among available immunotherapies [1]. This evidence concerns the gene MRC1 and mumps infectious disease.